Swiss Medica Inc., Innovative Products That Improve Peoples' Lives

7/22/2004 8:09:31 AM ET

SWISS MEDICA ANNOUNCES US $232,000 NET PURCHASE ORDER FROM 878 SHOPPERS DRUG MART

STORES

FOR IMMEDIATE RELEASE

Stock Symbol: OTC BB: SWME

July 22, 2004

SWISS MEDICA ANNOUNCES US $232,000 NET PURCHASE ORDER FROM 878 SHOPPERS DRUG MART

STORES

Toronto, Canada - Grant Johnson, President and COO of Swiss Medica (OTCBB: SWME), is pleased to

announce Shoppers Drug Mart (TSE: SC) has placed a net purchase order for the O24 pain relief product for its

878 stores in every Canadian province and two territories, totaling approximately US$232,000 (C$308,494). The

O24 patented all-natural product will be included on the shelves in the pain relief section of all their stores.

Grant Johnson said, "This is a banner day for Swiss Medica. Michael Bain, and our sales and marketing team,

have done a tremendous job in responding to the needs of Shoppers Drug Mart to make this happen. I am

proud of our people and honored to have the opportunity to work with Canada's largest chain drug store, which

is also the 5th largest chain in North America."

Raghu Kilambi, Chief Executive Officer of Swiss Medica said, "Our team's persistent efforts, leading up to the

San Diego NACDS and now during the follow-up stage, have begun to show the results we anticipated."

Swiss Medica will deliver the entire O24 shipment to all Shoppers Drug Mart stores this summer, and will

recognize the net revenues of US$232,000 from this purchase order in its third quarter income statement,

ending September 30th.

Shoppers Drug Mart Corporation is one of the most recognized and trusted names in Canadian retailing. The

Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart

(Pharmaprix in Quebec). With 878 Shoppers Drug Mart and Pharmaprix stores operating in prime locations in

every province and two territories, the Company is one of the most convenient retailers in Canada. The

Company also owns and operates 48 Shoppers Home Health Care stores, making it the largest Canadian

retailer of home health care products and services. First quarter 2004 sales increased to CDN$1.4 billion.

About Swiss Medica Inc.

Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our

market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be

a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please

visit our websites at www.swissmedica.com and

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the

United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking

statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close

transactions being contemplated, risks related to international sales and potential foreign currency exchange

fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological

changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s

periodic reports filed with the United States Securities and Exchange Commission and other regulatory

authorities.

Investor Relations Contact:

David Jones

Swiss Medica Inc.

1 866 485 4243